| Literature DB >> 24949622 |
Fabian Lenhard1, Sarah Vigerland1, Erik Andersson1, Christian Rück1, David Mataix-Cols1, Ulrika Thulin1, Brjánn Ljótsson1, Eva Serlachius1.
Abstract
BACKGROUND: International guidelines recommend Cognitive Behavior Therapy (CBT) as the first line treatment for pediatric obsessive-compulsive disorder (OCD). However, a substantial proportion of patients do not have access to such treatment. We developed and tested the feasibility, efficacy and acceptability of a novel therapist-guided, Internet-delivered CBT (ICBT) platform for adolescents with OCD.Entities:
Mesh:
Year: 2014 PMID: 24949622 PMCID: PMC4065049 DOI: 10.1371/journal.pone.0100773
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Demographic and clinical characteristics of the study sample (N = 21).
| Variablea |
| % | |
|
|
| 14.4 (2.64) | |
| min – max | 12.3–17.3 | ||
|
| Girls | 13 | 61.9% |
| Boys | 8 | 38.1% | |
|
| Mother | 4 | 19% |
| Father | 1 | 4.8% | |
| Both parents | 11 | 52.4% | |
| Alternating | 5 | 23.8% | |
|
| Swedish | 17 | 81% |
| Other European | 4 | 19% | |
|
| Swedish | 19 | 90.5% |
| Other European | 1 | 4.8% | |
| Middle East | 1 | 4.8% | |
|
| Swedish | 20 | 95.2% |
| Other European | 1 | 4.8% | |
|
| Primary | 3 | 14.3% |
| Secondary | 7 | 33.3% | |
| University | 11 | 52.4% | |
|
| Primary | 0 | 0% |
| Secondary | 4 | 19% | |
| University | 17 | 81% | |
|
| None | 17 | 81% |
| Methylphenidate | 3 | 14.3% | |
| Antiepileptic | 1 | 4.8% | |
|
| None | 12 | 57.1% |
| Unspecified | 6 | 28.6% | |
| CBT (without ERP) | 2 | 9.5% | |
| CBT (with ERP) | 1 | 4.8% | |
|
| Specific phobia | 8 | 38.1% |
| GAD | 7 | 33.3% | |
| ADHD | 5 | 23.8% | |
| Separation anx. | 3 | 14.3% | |
| Social phobia | 3 | 14.3% | |
| Depression | 2 | 9.5% | |
| Conduct disorder | 1 | 4.8% | |
|
| None | 6 | 28.6% |
| One | 5 | 23.8% | |
| Two | 7 | 33.3% | |
| Three | 2 | 9.5% | |
| Four | 1 | 4.8% | |
|
|
| 3.87 (2.64) | |
| Min – max | 0.5–10.4 |
Note aAbbreviations: CBT = Cognitive Behavior Therapy, ERP = Exposure and response prevention, GAD = Generalized anxiety disorder, ADHD = Attention deficit hyperactivity disorder, Separation anx = Separation anxiety disorder.
Figure 1Study flow chart.
An overview of the content of the ICBT treatment protocol.
| Treatment phase | Chapter | Parent chapters | Adolescent chapters |
|
| 1 | Introduction to ICBT | Introduction to ICBT |
| 2 | About OCD | What is OCD? | |
| 3 | We are cracking the code: The OCD circle | ||
| 4 | Exposure and response prevention | Building a hierarchy | |
|
| 5 | Testing exposure | |
| 6 | Being an exposure coach | Planning your ERP training | |
| 7 | New steps with ERP | ||
| 8 | When the family has OCD | ERP – frequent problems and solutions | |
| 9 | More new steps with ERP | ||
| 10 | Talking back to OCD - Coping with obsessions | ||
|
| 11 | The final sprint | |
| 12 | Your treatment in the rear-view mirror |
Figure 2Screenshot of an animated psychoeducation film from BiP OCD (Chapter 1).
Outcome measures’ means (M) and standard deviations (SD) at pre-, post-treatment and follow-upa.
|
| pre | post | 3-month FU | 6-month FU | ||||
|
|
|
|
|
|
|
|
|
|
| CY-BOCS | 21.33 | 3.54 | 12.05** | 4.51 | 8.8** | 5.11 | 9.14 | 6.41 |
| C-GAS | 56.1 | 6.28 | 71.5** | 9.32 | 73.95 | 8.99 | 73.48 | 9.69 |
|
| ||||||||
| ChOCI-R symptom | 13.57 | 8.71 | 6.43** | 6.6 | 5.31 | 6.74 | 5.00 | 6.61 |
| ChOCI-R impairment | 22.57 | 8.08 | 11.62** | 6.34 | 9.88 | 8.87 | 10.38 | 9.09 |
| COIS-R | 17.33 | 15.49 | 6.57** | 7.9 | 5.19 | 8.38 | 6.00 | 8.99 |
| SCAS OCD subscale | 9.05 | 4.96 | 4.05** | 3.41 | 2.88 | 3.76 | 3.25 | 3.98 |
| SCAS without OCD | 30.43 | 16.91 | 20.24** | 13.54 | 18.94 | 14.01 | 18.25 | 14.24 |
| CDI-S | 9.62 | 1.4 | 9.86 | 1.15 | 2.5** | 2.73 | 2.19 | 2.14 |
| SDQ | 13.52 | 5.52 | 10.57 | 4.02 | 10.69 | 4.22 | 10.50 | 4.84 |
|
| ||||||||
|
| 12.35 | 6.76 | 6.50** | 5.07 | 5.26 | 5.58 | 4.53 | 4.33 |
|
| 24.90 | 7.03 | 17.8** | 9.95 | 12.37* | 8.1 | 11.47 | 6.41 |
| COIS-R | 25.25 | 16.09 | 16.75* | 17.15 | 13.00 | 15.65 | 13.88 | 15.02 |
| FAS-PR | 14.60 | 8.44 | 9.60* | 7.09 | 6.89 | 8.05 | 6.47 | 6.91 |
| SCAS OCD subscale | 7.33 | 4.22 | 4.25* | 3.24 | 3.16 | 3.1 | 2.76 | 3.01 |
| SCAS without OCD | 25.24 | 15.73 | 16.00** | 13.54 | 16.37 | 12.24 | 15.65 | 14.13 |
| SDQ | 12.0 | 6.71 | 10.3 | 6.34 | 10.32 | 6.63 | 9.65 | 6.44 |
Note aUncorrected means and standard deviations,
Abbreviations: CY-BOCS = Children Yale-Brown Obsessive Compulsive Scale, C-GAS = Children’s Global Assessment Scale, ChOCI-R symptom/impairment = Children’s Obsessive Compulsive Inventory Revised symptom and impairment scales, COIS-R = Child Obsessive-Compulsive Impairment Scale Revised, SCAS = Spence Child Anxiety Scale, CDI-S = Children’s Depression Inventory – Short version, FAS-PR = Family Accommodation Scale Parent Rating, SDQ = Strength and Difficulties Questionnaire. *p<.05; **p<.001, p values refer to comparisons from pre-treatment to post, post-treatment to 3-month follow-up, and 3-month follow-up to 6-month follow-up, respectively.
Outcome measures’ effect sizes, ES (Cohen’s d) at pre-, post-treatment and follow-up.
|
| pre/post | post/3-month FU | 3-month FU/6-month FU | pre/6-month FU | ||||
|
|
|
|
|
|
|
|
|
|
| CY-BOCS | 2.29 | (1.50–3.07) | 0.67 | (0.04–1.3) | 0.05 | (−0.56–0.66) | 2.35 | (1.50–3.18) |
| C-GAS | −1.94 | (−2.60–−1.12) | −0.27 | (−0.93–0.30) | −0.06 | (−0.67–0.55) | −2.12 | (−2.90–−1.32) |
|
| ||||||||
| ChOCI-R symptom | 0.92 | (0.28–1.56) | 0.17 | (−0.49–0.82) | 0.05 | (−0.65–0.74) | 1.09 | (0.38–1.78) |
| ChOCI-R impairment | 1.51 | (0.81–2.18) | 0.23 | (−0.42–0.88) | −0.06 | (−0.75–0.64) | 1.43 | (0.68–2.16) |
| COIS-R | 0.88 | (0.24–1.50) | 0.17 | (−0.48–0.82) | −0.09 | (−0.79–0.60) | 0.86 | (0.18–1.54) |
| SCAS OCD subscale | 1.17 | (0.51–1.83) | 0.33 | (−0.33–0.98) | −0.10 | (−0.79–0.60) | 1.27 | (.55–1.98) |
| SCAS without OCD | 0.67 | (0.04–1.28) | 0.09 | (−0.56–0.74) | 0.05 | (−0.64–0.74) | 0.77 | (0.09–1.44) |
| CDI-S | −0.19 | (−0.79–0.42) | 3.7 | (2.61–4.77) | 0.13 | (−0.57–0.82) | 4.24 | (2.88–5.58) |
| SDQ | 0.61 | (−0.01–1.23) | −0.03 | (−0.68–0.62) | 0.04 | (−0.65–0.73) | 0.58 | (0.09–1.24) |
|
| ||||||||
|
| 0.94 | (0.29–1.58) | 0.23 | (−0.4–0.86) | 0.15 | (−0.51–0.80) | 1.31 | (0.59–2.01) |
|
| 0.79 | (0.15–1.42) | 0.60 | (−0.05–1.24) | 0.12 | (−0.53–0.78) | 1.94 | (1.15–2.71) |
| COIS-R | 0.45 | (−0.17–1.07) | 0.23 | (−0.4–0.86) | −0.06 | (−0.71–0.60) | 0.67 | (0.00–1.32) |
| FAS-PR | 0.60 | (−0.03–1.22) | 0.36 | (−0.28–0.99) | 0.06 | (−0.60–0.71) | 1.00 | (0.31–1.67) |
| SCAS OCD subscale | 0.82 | (0.17–1.45) | 0.34 | (−0.29–0.97) | 0.13 | (−0.53–0.78) | 1.22 | (0.52–1.92) |
| SCAS without OCD | 0.63 | (0.0–1.25) | −0.03 | (−0.66–0.59) | 0.05 | (−0.60–0.71) | 0.64 | (−0.02–1.29) |
| SDQ | 0.29 | (−0.33–0.91) | 0.0 | (−0.63–0.63) | 0.10 | (−0.55–0.76) | 0.39 | (−0.26–1.03) |
Note aAbbreviations: CY-BOCS = Children Yale-Brown Obsessive Compulsive Scale, C-GAS = Children’s Global Assessment Scale, ChOCI-R symptom/impairment = Children’s Obsessive Compulsive Inventory Revised symptom and impairment scales, COIS-R = Child Obsessive-Compulsive Impairment Scale Revised, SCAS = Spence Child Anxiety Scale, CDI-S = Children’s Depression Inventory – Short version, FAS-PR = Family Accommodation Scale Parent Rating, SDQ = Strength and Difficulties Questionnaire.
Figure 3Mean CY-BOCS and adolescent- respective parent-rated ChOCI-R impairment subscale scores at pre-treatment, post-treatment and follow-up.